IDIA — Idorsia Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual income statement for Idorsia, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	35.3	97.1	152	113	221
Cost of Revenue
Gross Profit	—	90.8	145	76.6	200
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	648	900	408	345	254
Operating Profit	-613	-803	-255	-232	-33.1
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-635	-820	-294	-263	-106
Provision for Income Taxes
Net Income After Taxes	-635	-828	-298	-264	-112
Minority Interest
Net Income Before Extraordinary Items
Net Income	-635	-828	-298	-264	-112
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-635	-828	-298	-264	-112
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-3.77	-4.67	-2.72	-1.82	-0.909
Dividends per Share